Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Innate Immunity is Scopus-indexed (Q2, CiteScore 5.4), WoS SCIE, DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1753-4259Verify ISSN ↗1753-4267Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 108 / 361 | 70th | Q2 |
| Microbiology | 87 / 194 | 55th | Q2 |
| Immunology | 112 / 243 | 54th | Q2 |
| Molecular Biology | 208 / 414 | 49th | Q3 |
| Cell Biology | 159 / 289 | 45th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present (also 1999, 1996–1997), best quartile Q2, CiteScore 5.4.
Innate Immunity is Q2 in Infectious Diseases (rank 108 of 361), Q2 in Microbiology (rank 87 of 194) and Q2 in Immunology (rank 112 of 243), by CiteScore 2025. It is ranked in 5 subject areas in all.
Innate Immunity is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.4, which places it in quartile Q2 at the 70th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.926, quartile Q2, with an H-index of 84.
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Innate Immunity is published by SAGE Publications Ltd. Its print ISSN is 1753-4259 and its online ISSN is 1753-4267.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Innate Immunity has an h-index of 73 and a 2-year mean of 2.96 citations per paper (OpenAlex). Its Scopus CiteScore is 5.4, quartile Q2. On 2-year citations it ranks #102 of 354 Scopus journals in Infectious Diseases.
Innate Immunity published 26 papers in 2025; its busiest recent year was 2019 with 93. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2021–2026), authors are most often from China (36.6%), United States (14.8%) and France (5.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 11 retracted papers are recorded (10.4 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.